Fig. 9From: Computational prediction of plasma protein binding of cyclic peptides from small molecule experimental data using sparse modeling techniquesStructures of a oritavancin (cyclic peptide drug), b Pep.1 (synthetic cyclic peptide), c acetyl-daptomycin (cyclic peptide drug), and d daptomycin (cyclic peptide drug), with the fraction of PPB (fb). The dashed magenta rectangles highlight the structural difference of c and dBack to article page